chr17-17219138-C-A

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_144997.7(FLCN):​c.943G>T​(p.Glu315*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E315E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 31)

Consequence

FLCN
NM_144997.7 stop_gained

Scores

4
2
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 5.28

Publications

4 publications found
Variant links:
Genes affected
FLCN (HGNC:27310): (folliculin) This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
FLCN Gene-Disease associations (from GenCC):
  • Birt-Hogg-Dube syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Birt-Hogg-Dube syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
  • familial spontaneous pneumothorax
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • renal carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • colorectal cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-17219138-C-A is Pathogenic according to our data. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-17219138-C-A is described in CliVar as Pathogenic. Clinvar id is 141706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLCNNM_144997.7 linkc.943G>T p.Glu315* stop_gained Exon 9 of 14 ENST00000285071.9 NP_659434.2 Q8NFG4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLCNENST00000285071.9 linkc.943G>T p.Glu315* stop_gained Exon 9 of 14 1 NM_144997.7 ENSP00000285071.4 Q8NFG4-1
ENSG00000264187ENST00000427497.3 linkn.149-84G>T intron_variant Intron 4 of 11 1 ENSP00000394249.3 J3QW42
FLCNENST00000577591.1 linkn.-35G>T upstream_gene_variant 2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00000535
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Dec 18, 2014
Clinical Genetics and Genomics, Karolinska University Hospital
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 15, 2023
Clinical Genetics Laboratory, Skane University Hospital Lund
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Pathogenic:1
Feb 14, 2014
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.E315* pathogenic mutation (also known as c.943G>T) located in coding exon 6 of the FLCN gene, results from a G to T substitution at nucleotide position 943. This changes the amino acid from a glutamic acid to a stop codon within coding exon 6. This alteration was previously described in an isolated familial pneumothorax cohort (Graham RB et al. Am. J. Respir. Crit. Care Med. 2005; 172:39-44). In addition to the clinical data presented in the literature, sincepremature stop codons are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -

Birt-Hogg-Dube syndrome Pathogenic:1
Aug 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Glu315*) in the FLCN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLCN are known to be pathogenic (PMID: 15852235). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Birt-Hogg-Dubé syndrome (PMID: 15805188). ClinVar contains an entry for this variant (Variation ID: 141706). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.62
CADD
Pathogenic
36
DANN
Uncertain
1.0
Eigen
Pathogenic
0.84
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.97
D
PhyloP100
5.3
Vest4
0.75
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587781952; hg19: chr17-17122452; API